North Carolina Glaxosmithkline
The North Carolina GlaxoSmithKline Foundation is a corporate foundation headquartered in Research Triangle Park, North Carolina. Established in 1986, it operates as an independent 501(c)(3) organization with its own endowment, separate from its corporate parent. The foundation is dedicated to supporting nonprofit organizations across North Carolina that address educational and health needs.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$71.7M
+4.8% YoY
Annual Giving
$3.2M
-7.2% YoY
Grant Count
16
+0.0% YoY
Avg Grant Size
$199K
-7.2% YoY
Mission & Focus Areas
The foundation supports programs designed to promote education, health, and science. The organization works to build coalitions of individuals and organizations to combine resources and focus efforts on meeting critical educational needs throughout the state.
Grantmaking
The foundation operates several grant programs:
Grant Range
$25,000 and above
Ready to take the next step with North Carolina Glaxosmithkline?
Geographic Focus
Where this funder awards grants
The foundation focuses exclusively on North Carolina, supporting statewide nonprofit organizations and educational institutions throughout the state.
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
Assets & Revenue (2024)
- Total Assets: $71.7 million
- Total Revenue: $4.52 million
- Total Expenses: $2.47 million
- Net Income: $2.04 million
- Net Assets: $70.06 million
Annual Giving
- Current annual giving: approximately $3 million
- Giving rate: 3.6% of assets
Historical Context
- Total grants awarded since 1986: $96.2 million
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $71,693,024 | $68,434,707 | $63,366,755 |
| Revenue | $4,515,329 | $2,880,831 | $4,670,887 |
| Expenses | $2,470,599 | $1,574,508 | $3,947,232 |
| Qualifying Distributions | $3,719,962 | $4,552,977 | $3,827,048 |
| Net Investment Income | $4,221,482 | $2,370,359 | $4,421,377 |
| Distributable Amount | $3,442,783 | $2,753,042 | $2,809,167 |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
80 grants across all recorded years
Open Grants
1 open opportunity from North Carolina Glaxosmithkline
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Leadership team and compensation from IRS filings
- Melissa Chappell - Executive Director
- JaNel Moore - Administrative Staff
- Dawn Lloyd - Program Officer
- Alicia Penny - Fiscal Analyst
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| MARILYN E FOOTE-HUDSON | FORMER EXECUTIVE DIRECTOR | 40 | — |
| MARGARET B DARDESS | CHAIRPERSON | 0.46 | $4,000 |
| GEORGE B ABERCROMBIE | PRESIDENT | 0.46 | $4,000 |
| PAUL A HOLCOMBE JR | SECRETARY | 0.46 | $4,000 |
| THOMAS R HABER | TREASURER | 0.46 | $4,000 |
| ADRIANNA CARTER | DIRECTOR | 0.46 | $4,000 |
| JOHN FAV CECIL | DIRECTOR | 0.46 | $3,000 |
| RAN COBLE | DIRECTOR | 0.46 | $3,000 |
| SHIRLEY T FRYE | DIRECTOR | 0.46 | $4,000 |
| ANN B GOODNIGHT | DIRECTOR | 0.46 | $3,000 |
| DR CHARLES SANDERS | DIRECTOR | 0.46 | $3,000 |
| S MARK WERNER | DIRECTOR | 0.46 | $4,000 |
| JANICE M WHITAKER | DIRECTOR | 0.46 | $4,000 |
| MELISSA CHAPPELL | EXECUTIVE DIRECTOR | 40 | — |
Recent Activity
Recent developments and announcements
As of December 2025, the foundation has paused its grant application portal while developing a new strategic plan. The foundation's revised strategy and grantmaking approach are expected to be announced by mid-2026. This represents a significant transition period for the organization as it reassesses its funding priorities and operational approach.
North Carolina GlaxoSmithKline Foundation Awards Grants to Promote Health,Contact Information
Mailing Address: 410 Blackwell Street Durham, North Carolina 27701
Phone: 919-483-2140
Website: www.ncgskfoundation.org
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with North Carolina Glaxosmithkline on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities